Abstract
Based on real-life data for the stage distribution of COPD patients (GOLD) and the actual stage-related treatment costs in a large nationwide cohort study (COSYCONET) [1], the influence of the reduced smoking rate on treatment costs was determined for the scenario of a reduction in the smoking rate of 26% in this patient group by 10 percentage points to 16 %. The assumption was made that with a reduced smoking rate, lower stages (I/II) will be more strongly represented, while higher and more cost- intensive stages (III/IV) will be proportionally reduced. The intervention to achieve tobacco abstinence was calculated for the rough model calculations with the typical costs of a guideline-compliant treatment by a behavioral therapy group cessation program and the parallel use of medication support [2, 3]. The result showed a potential reduction of case costs by 10.5%, not including reduction in costs associated with treatment of comorbidities.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Fakultät: | Medizin > Institut und Poliklinik für Arbeits-, Sozial- und Umweltmedizin |
Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
ISSN: | 0934-8387 |
Sprache: | Deutsch |
Dokumenten ID: | 98911 |
Datum der Veröffentlichung auf Open Access LMU: | 05. Jun. 2023, 15:30 |
Letzte Änderungen: | 24. Apr. 2024, 11:31 |